Status:
COMPLETED
CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）
Lead Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Collaborating Sponsors:
Keio University
Jikei University School of Medicine
Conditions:
Cervical Cancer
Eligibility:
FEMALE
30-64 years
Phase:
PHASE4
Brief Summary
The aim of this study is to assess efficacy of the screening with concurrent liquid-based cytology and HPV DNA testing for the primary cervical cancer screening over 7 years.
Eligibility Criteria
Inclusion
- Women aged 30-64 years old
- Participants provided written informed consent
Exclusion
- Women who
- will receive planed HPV DNA testing by local governmental cervical cancer program next six years
- have had cervical invasive cancer before
- have undergone cervical conization
- have undergone hysterectomy
- have had or have the cytological abnormalities and are under follow-up
- are pregnant
- are judged ineligible for this trial by physician
Key Trial Info
Start Date :
June 7 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
18471 Patients enrolled
Trial Details
Trial ID
NCT01895517
Start Date
June 7 2013
End Date
May 31 2023
Last Update
June 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Medicine, Keio University
Shinjuku, Tokyo, Japan, 160-8582